Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Minerva Neurosciences (NERV) stocks in Canada
Learn how to easily invest in Minerva Neurosciences stocks.
Minerva Neurosciences is a biotechnology business based in the US. Minerva Neurosciences stocks (NERV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.8 – a decrease of 10.65% over the previous week. Minerva Neurosciences employs 11 staff and has a market cap (total outstanding stock value) of $31.2 million.
How to buy shares in Minerva Neurosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NERV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Minerva Neurosciences?
- Has coronavirus impacted Minerva Neurosciences shares?
- Minerva Neurosciences shares summary
- Compare share dealing platforms
- Is Minerva Neurosciences stock a buy or sell?
- Minerva Neurosciences performance over time
- Minerva Neurosciences's financials
- How volatile are Minerva Neurosciences shares?
- Does Minerva Neurosciences pay a dividend?
- Other common questions
Minerva Neurosciences stock price (NASDAQ:NERV)Use our graph to track the performance of NERV stocks over time.
Minerva Neurosciences shares at a glance
|Latest market close||$0.73|
|52-week range||$0.71 - $3.69|
|50-day moving average||$0.95|
|200-day moving average||$1.81|
|Wall St. target price||$7.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.84|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Minerva Neurosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Minerva Neurosciences price performance over time
|1 week (2022-01-19)||-10.67%|
|1 month (2021-12-23)||-24.34%|
|3 months (2021-10-26)||-46.72%|
|6 months (2021-07-26)||-61.38%|
|1 year (2021-01-26)||-78.65%|
|2 years (2020-01-24)||-90.89%|
|3 years (2019-01-25)||7.08|
|5 years (2017-01-26)||10.35|
Is Minerva Neurosciences under- or over-valued?
Valuing Minerva Neurosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Minerva Neurosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Minerva Neurosciences's EBITDA
Minerva Neurosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.6 million.
The EBITDA is a measure of a Minerva Neurosciences's overall financial performance and is widely used to measure a its profitability.
Minerva Neurosciences financials
|Gross profit TTM||$19.1 million|
|Return on assets TTM||-24.03%|
|Return on equity TTM||-83.45%|
|Market capitalisation||$31.2 million|
TTM: trailing 12 months
Minerva Neurosciences share dividends
We're not expecting Minerva Neurosciences to pay a dividend over the next 12 months.
Minerva Neurosciences share price volatility
Over the last 12 months, Minerva Neurosciences's shares have ranged in value from as little as $0.71 up to $3.693. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Minerva Neurosciences's is 0.886. This would suggest that Minerva Neurosciences's shares are less volatile than average (for this exchange).
Minerva Neurosciences overview
Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, a compound in Phase III clinical trial for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc.
Stocks similar to Minerva Neurosciences
Minerva Neurosciences in the news
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.